Lux Capital Management

by in

Entry	Author	Date	Location
Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs	Luke Timmerman	02/28/13	Boston
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News	Erin Kutz	01/07/11	Boston
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News	Rebecca Zacks	01/05/11	Boston
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News	Rebecca Zacks	02/25/09	Boston
Vertex’s $320M SPO, Verenium and BP’s Joint Venture, Genocea’s $23M Series A, & More Boston-Area Deals News	Rebecca Zacks	02/20/09	Boston
Genocea Biosciences Closes $23M Series A, Adds New CEO Bakali	Ryan McBride	02/19/09	Boston
Page 1 of 1

Xconomy National